DIN 02496933 — AVSOLA 100 MG
AVSOLA is a powder for solution of Infliximab marketed by AMGEN CANADA INC. The full Infliximab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02496933
- Brand name
- AVSOLA
- Active ingredient
- Infliximab
- Strength
- 100 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Tumour necrosis factor (TNF)-alpha inhibitor (biologic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Infliximab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02523191 | IXIFI | 100 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02419475 | REMDANTRY | 100 MG | POWDER FOR SOLUTION | CELLTRION INC. | MARKETED |
| 02244016 | REMICADE | 100 MG | POWDER FOR SOLUTION | JANSSEN INC | MARKETED |
| 02511584 | REMSIMA SC | 120 MG | KIT; SOLUTION | CELLTRION INC. | MARKETED |
| 02470373 | RENFLEXIS | 100 MG | POWDER FOR SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |